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Abstract
Background: The amount of CD4 T cells is used for monitoring HIV progression and
improvement, and to make decisions to start antiretroviral therapy and prophylactic drugs for
opportunistic infections. The aim of this study was to determine normal reference values for CD4
T cells, lymphocytes, leucocytes and haemoglobin level in healthy, HIV negative adolescents and
adults in rural northern Tanzania.
Methods: A cross sectional study was conducted from September 2006 to March 2007 in rural
northern Tanzania. Participants were recruited from voluntary HIV counselling and testing clinics.
Patients were counselled for HIV test and those who consented were tested for HIV. Clinical
screening was done, and blood samples were collected for CD4 T cell counts and complete blood
cell counts.
Results: We enrolled 102 participants, forty two (41.2%) males and 60 (58.8%) females. The mean
age was 32.6 ± 95% CI 30.2–35.0. The mean absolute CD4 T cell count was 745.8 ± 95% CI 695.5–
796.3, absolute CD8 T cells 504.6 ± 95% CI 461.7–547.5, absolute leukocyte count 5.1 ± 95% CI
4.8–5.4, absolute lymphocyte count 1.8 ± 95% CI 1.7–1.9, and haemoglobin level 13.2 ± 95% CI
12.7–13.7. Females had significantly higher mean absolute CD4 T cell count (p = 0.008), mean
absolute CD8 T cell count (p = 0.009) and significantly lower mean haemoglobin level than males
(p = 0.003)
Conclusion: Immunohaematological values found in this study were different from standard values
for western countries. Females had significantly higher mean CD4 T cell counts and lower mean
haemoglobin levels than males. This raises the issue of the appropriateness of the present reference
values and guidelines for monitoring HIV/AIDS patients in Tanzania.
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Immunohaematological indices such as leukocytes, lym-
phocytes and their subsets play a major role in both cellu-
lar and humoral types of immunity. CD4 T cells are the
lymphocytes used for monitoring progression of HIV
infection, and they are also used as a surrogate marker for
the improvement of HIV patients after initiation of anti
retro-viral (ARV) therapy [1-5]. Furthermore, CD4 T cell
level determines when to start or stop prophylactic drugs
for opportunistic infections [2,3,6]. Management of HIV
patients include proper monitoring, irrespective of ARV
treatment. This monitoring can be done clinically by
means of the WHO clinical staging, but more reliably by
measuring CD4 T cells and viral load [2,3]. Immunohae-
matological variations have been reported in various stud-
ies, showing association with sex, [7,8] geographical
location, race, altitude and diet [7,9-12]. Other reasons for
variations are pregnancy, age, [13,14] exercise, cormobid
conditions and diurnal variation [15-17], in addition to
variations caused by methodological differences. Several
studies have shown significant variations of CD4 T cells
within African populations and in Africans compared
with the values established for Europe and North America
[12,18-26]. This justifies the importance of establishing
local immunological reference values for the local African
population. We report on immunohaematological indi-
ces in HIV negative, healthy individuals in rural Tanzania.
Methods
Study design, setting and population
A cross sectional study was conducted in three Divisions:
Dongobesh in Mbulu District, Basotu in Hanang District
(both in Manyara Region) and Nduguti in Iramba District
(Singida Region). The total population in these three divi-
sions is about 250,000 [27]. In each division there are
mobile HIV voluntary counselling and testing (VCT) serv-
ices which are conducted once per month in each ward in
the respective divisions. The VCT services are under Hay-
dom Lutheran Hospital which is owned by The Evangeli-
cal Lutheran Church in Tanzania, Mbulu Diocese.
Study subjects
Study subjects were adolescents and adults who attended
HIV-VCT from September 2006 to March 2007. Eligible
subjects were those aged 10 years and above and who
agreed to participate in the study. Those who consented
were asked for blood samples for repeat HIV test, CD4 T
cell and CD8 T cell counts, and complete blood cell count
(CBC). Blood was collected in ethylene diamine-tetra-ace-
tic acid (EDTA) tubes. The same samples were used for
repeat HIV test, CBC, CD4 T cell and CD8 T cell counts.
Samples were collected in the morning from 9.00 AM to
12.00 noon and kept at room temperature and transferred
to Haydom hospital for analysis within the same day.
Subjects were interviewed, using a structured question-
naire, and screened for symptoms such as fever, cough
and weight loss to rule out any recent and/or current
infections. Blood slide for malaria was done for all partic-
ipants, in addition to a physical examination, including
measurement of height and weight.
The following categories were excluded: pregnant (1),
smokers (8), patients receiving medical treatment, indi-
viduals with history of recent or current cormobid condi-
tions, chronic alcoholism and moderate and severe
malnourishment (BMI< 17.5 Kg/m2) [28] (9), patients




HIV test was done using 2 different rapid antibody tests,
Determine HIV-1/2 (Abbott laboratories, Abbott Park, IL,
USA) and Capillus HIV-1/2 (Trinity Biotech, Bray, Co
Wicklow, Ireland). Concordant positive results were inter-
preted as positive for HIV antibody. Discordant results
were interpreted as inconclusive and the samples were
sent to the regional hospital for confirmatory test using
ELISA; Enzygnost anti-HIV 1+2 Plus ELISA (Behring, Mar-
burg, Germany) and Well-coenzyme HIV recombinant
ELISA (Murex, Dartford, England) [29,30].
Haematological analysis
Complete blood cell counts were done using Sysmex Kx-
21 (Sysmex Corporation; Kobe Japan). The machine auto-
matically dilutes a whole-blood sample, lyses, counts and
gives a printout result of absolute numbers of leucocytes
(expressed as number of cells × [109] per liter), erythro-
cytes (number of cells × [1012] per liter), platelets
(number of cells × [109] per liter), lymphocytes (number
of cells × [109] per liter), mononuclear cells (number of
cells × [109] per liter), granulocytes (number of cells ×
[109] per liter) and haemoglobin (grams per decilitre).
The quality and accuracy of the technique and the
machine was assessed every six months.
CD4 T cell counts
CD4 T cells were analyzed using a FACSCount flow
cytometer (Becton Dickinson Immunocytometry Systems,
San Jose, Calif.). In brief, 50 μl of whole blood was mixed
and incubated at room temperature for 20 min with 20 μl
of aCD4 and aCD8. Red blood cells were then lysed by
adding 450 μl of fluorescence-activated cell sorter lysing
solution (Becton Dickinson Immunocytometry Systems).
The tubes were incubated at room temperature for 10
min, and then analyzed with the FACSCounts's Cell Quest
software (Becton Dickinson Immunocytometry Systems)
within six hours. By using quality control (Multicheck;Page 2 of 7
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racy of the technique was assessed every 6 months.
Screening for Malnutrition
All participants were assessed for malnutrition using body
mass index (BMI). Normal nutritional status was defined
as BMI>18.5 Kg/m2, mild malnutrition as BMI of 17.5–
18.4 Kg/m2, moderate malnutrition as BMI of 16–17.4
Kg/m2 and severe malnutrition as BMI of < 16 Kg/m2[28].
Data management and Statistical analysis
Completed questionnaires were coded by numbers and
double entered in a computer software Epi-data version
13.1. Cross-checking and data cleaning was done. The
data was then transferred to SPSS version 13 for analy-
sis[31] Chi-squire test was used to explore bivariate asso-
ciations for categorical variables. Where appropriate we
used student (t) test. Logistic regression was used to
explore the association of socio-demographics and other
variables with CD4 T cells. Odds ratio (OR) with 95%
confidence intervals (CI) was used.
Ethical considerations
The protocol was approved by the Medical Research Coor-
dinating Committee of the Ministry of Health and Social
Welfare, Tanzania. Oral informed consent was obtained
from the patients prior to enrolment. For those below the
age of 18 years permission was sought from parents or
caretakers.
Those found to have HIV infection on the repeat HIV test
were excluded from the study and referred to the HIV care
and treatment clinic for further management. HIV/AIDS
diagnosis, treatment and monitoring were given free of
charge according to Tanzanian national policy.
Results
Baseline characteristics of the study participants
Initially 129 persons volunteered to participate in the
study. After screening for current or recent comorbid con-
ditions, pregnancy and smoking we remained with 102
participants. Forty two (40%) were males and 60 (59%)
were females. The mean age was 32.6 ± 95% CI 30.2–35.0.
For males the mean age was 35.2 ± 95% CI 31.5–50.5 and
for females 30.9 ± 95% CI 49.5–68.5.
Immunohaematological parameters and sex
The results for the immunohaematological values are
given in table 1 and 2
Reference values are reported in percentiles in these tables
Females had higher mean absolute leukocyte counts and
lymphocyte counts than males (table 2). Females also had
significantly higher mean absolute CD4 T cells, (t = 2.7 df
= 89, p = 0.008) and higher mean absolute CD8 T cells (t
= 2.7, df = 90, p = 0.009) than males. For the haemoglobin
level females had significantly lower mean haemoglobin
level than males, (t = 3.2, df = 68, p = 0.03). Table 3 shows
the difference between males and females with lower than
Table 1: Arithmetic median, 2.5th–97.5th percentile, mean and 95% CI of the mean CD4 T cells, CD8 T cells, CD4/CD8 ratio and 
haemoglobin level
Sex n Median 2.5th–97.5th percentile Mean ± SD 95% CI of the Mean P value
Absolute CD4 T cells
Males 42 596.5 291.2–1278.9 665.6 ± 246.8 588.7–742.5 t = 2.7, df = 89,
p = 0.008
Females 60 764.5 288.5–1406.8 802.0 ± 250.2 737.4–866.7
Total 102 722.5 312.2–1367.6 745.9 ± 256.6 695.5–796.3
Absolute CD8 T cells
Males 42 417 145.9–977.3 438.2 ± 208.4 373.4–503.0 t = 2.7, df = 90,
p = 0.009
Females 60 513 171.7–1101.7 551.0 ± 215.4 495.4–606.7
Total 102 472 168.2–996.8 504.6 ± 218.6 461.7–547.5
CD4/CD8 T cells ratio
Males 42 1.6 1.0–3.7 1.6 ± 0.5 1.5–1.9 t = 1.2, df = 61,
p = 0.2
Females 60 1.5 1.1–2.4 1.5 ± 0.3 1.4–1.6
Total 102 1.5 1.1–2.5 1.6 ± 0.4 1.5–1.6
Haemoglobin level
Males 42 14.8 7.0–18.0 14.1 ± 2.7 13.3–14.9 t = 3.1, df = 68,
p = 0.003
Females 60 13.0 7.5–15.4 12.6 ± 1.9 12.0–13.1
Total 102 13.5 7.1–17.4 13.6 ± 2.4 12.7–13.7
Reference value are reported in percentilePage 3 of 7
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values. There was a statistical significance among partici-
pants with CD4 T cells <500 cells/mm3, where males had
significantly lower CD4 T cells than females (p = 0.01, OR
4.4, 95% CI 1.3–15). There was no statistically significant
difference between males and females having lower than
normal haemoglobin levels (X2 = 1.1, df = 1, p = 0.2),
lower than normal leucocytes (X2 = 0.1, df = 1, p = 0.7)
and lower than normal lymphocytes (X2 = 2.5, df = 1, p =
0.1)
Immunohaematological parameters and nutritional status
On nutritional status assessment using BMI 3 (3%) of the
participants had mild malnutrition (BMI 17.5–18.4) and
99 (97%) had normal nutritional status (BMI>18.5). The
mean BMI for the participants was 23.4 ± 95% CI 22.8–
24.1; Mean BMI for males was 23.3 ± 95% CI 22.0–24.5
and for females 23.6 ± 95% CI 22.8–24.3 (Table 2). There
was no statistically significant difference between males
and females in nutritional status (X2 = 0.07, df = 1, p =
0.8). There was no significant association between nutri-
tional status and any of the immunohaematological
Table 2: Arithmetic median, 2.5th–97.5th percentile mean and 95% CI of the mean leukocytes, lymphocytes and nutritional status
Sex n Median 2.5th–97.5th percentile Mean ± SD 95% CI of the Mean P value
Absolute leukocytes
Males 42 4.7 2.3–8.8 4.9 ± 1.6 4.4–5.4 t = 1.2, df = 91,
p = 0.2
Females 60 5.2 2.5–9.2 5.3 ± 1.7 4.8–5.7
Total 102 5.0 2.5–9.0 5.1 ± 1.6 4.8–5.4
Absolute lymphocytes
Males 42 1.5 0.6–3.2 1.6 ± 4.9 1.5–1.8 t = 0.3, df = 92,
p = 0.8
Females 60 1.8 0.3–4.7 1.9 ± 5.3 1.8–2.2
Total 102 1.7 0.6–3.5 1.8 ± 5.1 1.7–1.9
Nutritional status given as BMI in Kg/m2
Males 42 21.9 17.6–34.5 23.3 ± 3.9 22.0–24.5 t = 0.4, df = 71,
p = 0.7
Females 60 23.6 17.9–32.9 23.6 ± 2.9 22.8–24.3
Total 102 22.9 17.9–32.9 23.4 ± 3.4 22.8–24.1
Reference value are reported in percentile
Table 3: Males and females with lower than normal and normal values of CD4 T cells, leukocytes, lymphocytes, haemoglobin level and 
body mass index
Parameter Males Females Total P-value
CD4 T cells in cells/mm3 n % n %
<500 10 23.8 4 6.7 14 0.01
>500 32 76.2 56 93.3 88
Total 42 100 60 100 102
Leukocytes in cells/litre
<4.0 × 109 10 23.3 16 26.6 26 0.7
>4.0 × 109 32 76.2 44 73.4 76
Total 42 100 60 100 102
Lymphocytes in cells/litre
<1.0 × 109 8 19.0 5 8.3 13 0.1
> 1.0 × 109 34 81.0 55 91.7 89
Total 42 100 60 100 102
Haemoglobin level in g/dl
<10.0 4 9.5 10 16.7 14 0.1
>10.0 38 90.5 50 83.3 88
Total 42 100 60 100 102
Body mass index in kg/m2
17.0–18.4 1 2.4 2 3.3 3 0.7
>18.5 41 97.6 58 96.7 99
Total 42 100 60 100 102Page 4 of 7
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ysis.
Immunohaematological parameters and age
There was no statistically significant association between
age and any of the immunohaematological parameters.
Discussion
Absolute CD4 T cell counts and haemoglobin level are the
most important parameters for monitoring progression of
HIV to AIDS and also the improvement after initiation of
antiretroviral therapy (ARV). Tanzania is scaling up ARV
for people living with HIV/AIDS, and CD4 T cell counts
and haemoglobin level are the recommended parameters
for monitoring these patients [1-3]. In our study we found
that females have significantly higher counts of absolute
CD4 T cells and absolute CD8 T cells than males, and also
higher mean absolute leukocyte and lymphocyte counts.
Our results are similar to those reported in other studies
in African settings [7,8,12,32]. More important, our find-
ings are different from the standard values established for
Europe and Northern America [33]. There are also several
other studies done in Africa and Asia that report different
values for CD4 T cell levels compared to standard values
for Western countries [12,16,22]. Studies done in Tanza-
nia and Cameroon have reported higher CD4 T cell counts
as compared to Ethiopia, Botswana and Uganda [12,34-
37], whereas some studies have demonstrated higher CD4
T cells among Ugandans and Kenyans than the values
known for North America, Europe and Asia [32]. These
variations in CD4 T cells have been shown to be associ-
ated with ethnicity, gender, diet, geographical area, as well
as being dependent of genetic and environmental factors
[7,9-12]. The value of the CD4 T cell counts obtained in
our study is lower than those reported for Ethiopian and
the Dutch counterparts [34,38]
In our study significant proportion of males had lower
mean absolute CD4 T cell and absolute CD8 T cell counts
than females. This finding is similar to a study done in
Tanzania to determine gender difference in CD4 T cells,
which showed that males were more likely to have CD4 T
cells <500 cells/mm3[35]. In addition to the variation of
CD4 T cells with the above factors, the CD4 T cells varia-
tion with sex might complicate the management of peo-
ple living with HIV/AIDS, especially in decision making
for starting prophylaxis for opportunistic infections and
ARV.
Females had significantly lower haemoglobin levels than
males in our study. This is similar to findings in North
America, Europe and Asia. Overall we found low haemo-
globin levels compared to European values and the stand-
ard reference haemoglobin values. This can be partly
explained by low dietary intake of food rich in iron and
vitamins, which is the commonest causes of low haemo-
globin levels in Tanzania; In addition infections such as
malaria and worm infestations are well known cause of
low haemoglobin levels [39]. The values obtained for hae-
moglobin levels in this study is lower than the currently
value used in Tanzania. This shows that a significant pro-
portion of this population is anaemic, though we did not
explore the causes of anaemia in our study. Overall the
mean absolute leukocyte, lymphocyte and haemoglobin
levels are lower than the standard reference values used,
similar to other studies in Africa [12,32] The causes of
these variations are unknown, though genetic factors,
diet, altitude and environmental factors such as infections
can partly explain the differences[12,32]
The strengths of our study are that data were collected
from an African population living in a rural area in the
same environment as the patients. Blood samples were
collected and analysed within the same day. Also, we used
the currently recommended methods in Tanzania for enu-
merating the CD4 T cells and white blood cells, (FACS-
Count and automated haematology machine Sysmex Kx
21). A limitation of our study is that we have a small sam-
ple size. Also, though we ruled out obvious comorbid
conditions by clinical screening and laboratory investiga-
tions such as HIV test and blood slides for malaria, we
might had missed conditions such as latent tuberculosis
infection, asymptomatic syphilis and also HIV infection
during the window period because our HIV test can not
pick up HIV antibodies before 3 months. We might also
erroneously have excluded some of the participants
because of over-reporting of clinical symptoms used as
screening tool for inclusion.
Conclusion
Immunohaematological values found in this study were
different from the standard values for the western coun-
tries. Females had significantly higher mean CD4 T cell
and CD8 T cell counts and lower mean haemoglobin lev-
els than males. The important issue raised by our study,
and supported by other studies is: what are the conse-
quences of using western reference values and guidelines
for monitoring HIV/AIDS patients if the normal values for
the CD4 T cells are different in African context, and
females have higher CD4 T cells and CD8 T cells than
males? What are the implications for the initiation and
monitoring of patients on ARV and prophylactic drugs for
opportunistic infections? We believe it is time for a review
of the reference values for CD4 T cells and other immuno-
haematological parameters used to monitor patients, and
prepare guidelines according to local African findings.
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